News by date

Powered by mod LCA

GalChimia signs deal with HQL Pharmaceuticals

Monday, 19 September 2011 00:00 Written by Manufacturing Chemist

GalChimia, a Spanish provider of synthetic organic chemistry services is to work with HQL Pharmaceuticals for cancer research.

The Santiago de Compostela-based firm said it would work with the Israeli drug discovery firm to develop small molecules that cause programmed cell death by inhibiting protein-protein interactions targeting apoptotic pathways, which is said to play a key role in oncology.

read the whole news at Manufacturing Chemist